CrowdStrike Stock Surges 6.2%, Returns to IBD 50 Index
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Fazen Markets confirmed on May 22, 2026 that CrowdStrike Holdings has been reinstated to the IBD 50 list of elite growth stocks. The cybersecurity firm's stock price rose 6.2% on the session to close at $378.45, adding approximately $14.5 billion to its market capitalization. The move follows a sustained period of relative strength and a recent Q1 earnings beat that exceeded Wall Street's revenue and earnings per share estimates.
The IBD 50 targets stocks exhibiting strong earnings, price performance, and relative strength. CrowdStrike last held a position in the index in the third quarter of 2025 before being rotated out. The index is a tracked benchmark for many institutional momentum funds. The current macro backdrop features stable Treasury yields, with the 10-year note hovering near 4.3%. Equity markets have entered a rotational phase, with capital flowing from overbought mega-cap tech into sectors like cybersecurity. The immediate catalyst for CRWD's return to the index was a powerful 18.4% post-earnings rally in early May. This surge pushed the stock's Relative Strength Rating (RS Rating) above 90, a key IBD 50 selection threshold. Quarterly earnings per share growth accelerated to 37% year-over-year, up from 28% in the prior quarter.
CrowdStrike's current market capitalization stands at $92.1 billion. The stock is up 42% year-to-date, significantly outperforming the Nasdaq 100's 12% gain over the same period. Its forward price-to-earnings ratio is 67.3, which is a premium to the software sector median of 29.5 but in line with high-growth security peers. The IBD 50 list itself has outperformed the broader S&P 500 by an average of 4.2 percentage points annually over the past decade. The table below shows the magnitude of change in key metrics before and after the Q1 2026 earnings report.
| Metric | Pre-Earnings (30 Apr) | Post-Earnings (22 May) | Change |
|---|---|---|---|
| Stock Price | $319.80 | $378.45 | +18.4% |
| YTD Performance | +20.1% | +42.0% | +21.9 ppt |
| RS Rating | 87 | 95 | +8 points |
CrowdStrike's reinstatement channels fresh institutional capital into the cybersecurity sector, boosting peers like Palo Alto Networks and Zscaler. ETF inflows to the iShares Cybersecurity and Tech ETF (IHAK) accelerated by 15% week-over-week following the IBD 50 news. The move signifies a market rotation into growth stocks with proven profitability, a departure from speculative, pre-profit names. A key counter-argument is valuation risk; CRWD's premium multiple is vulnerable to any slowdown in new annual recurring revenue growth from the current 34% pace. Positioning data shows increased call option volume in CRWD, with open interest for June $400 calls rising 45%. Hedge fund net exposure to the security software subsector, as measured by prime broker reports, increased to a 6-month high.
Investors will monitor CrowdStrike's Q2 2027 earnings report, scheduled for August 28, 2026, for confirmation of sustained growth. The next IBD 50 weekly rebalance on June 2 will confirm CRWD's ongoing eligibility. Key price levels include a near-term support zone around $360, which aligns with the stock's 21-day exponential moving average. Resistance sits at the psychological $400 level, last tested in February 2025. A breach above $400 on sustained volume would confirm the breakout and could target the all-time high of $425.60. Any decline below the 50-day moving average near $340 would signal a failure of the IBD-driven momentum and likely trigger profit-taking.
The IBD 50 is a proprietary list maintained by Investor's Business Daily that identifies the top 50 growth stocks based on a composite of earnings, price performance, and momentum metrics. Inclusion is significant because the list is used as a stock-picking screen by many professional fund managers and algorithmic trading systems. This can lead to direct institutional buying as funds benchmarked to the index adjust their portfolios, creating a self-reinforcing rally.
CrowdStrike's return to the IBD 50 is part of a broader reshuffling that saw several cloud software names added. It is the only pure-play cybersecurity firm in the current cohort, joining companies like Datadog and Snowflake. Historically, stocks that re-enter the IBD 50 after an absence tend to outperform the index average for the subsequent quarter, with a median return of 8.2% versus 5.1% for continuous members.
CrowdStrike is a top-5 holding in major cybersecurity ETFs like IHAK and the First Trust NASDAQ Cybersecurity ETF (CIBR). Sustained strength in CRWD provides a significant tailwind for these funds' performance. ETF managers may need to overweight CRWD to track their indices properly, creating additional buying pressure. This dynamic often lifts the entire sector basket, benefiting smaller constituents through correlated flows.
CrowdStrike's IBD 50 reinstatement validates its post-earnings momentum and triggers systematic institutional buying.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.